Dose Proportionality of Different Dose Strengths of Linagliptin Tablets After Oral Administration to Healthy Male and Female Volunteers

NCT02183480 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Linagliptin, low dose
DRUG: Linagliptin, medium dose
DRUG: Linagliptin, high dose

Sponsor

Boehringer Ingelheim